For the year ending 2025-12-31, RMTG made $5,100,315 in revenue. -$7,812,409 in net income. Net profit margin of -153.18%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenue | 5,100,315 | |||
| Cost of revenue | 2,289,537 | |||
| Gross profit | 2,810,778 | |||
| Advertising and marketing | 716,698 | |||
| Professional fees | 1,390,146 | |||
| Officer compensation | 90,000 | |||
| Depreciation and amortization expense | 281,067 | |||
| Investor relations | 80,000 | |||
| General and administrative | 1,120,029 | |||
| Total operating expenses | 3,677,940 | |||
| Net income (loss) from operations | -867,162 | |||
| Interest expense | 7,447,780 | |||
| Change in fair value of derivative liability | 918,688 | |||
| Loss on extinguishment of debt | -416,155 | |||
| Total other income (expense) | -6,945,247 | |||
| Net loss | -7,812,409 | |||
| Basic EPS | -0.62 | |||
| Diluted EPS | -0.62 | |||
| Basic Average Shares | 12,634,310 | |||
| Diluted Average Shares | 12,634,310 | |||
Regenerative Medical Technology Group Inc. (RMTG)
Regenerative Medical Technology Group Inc. (RMTG)